Skip to main content
. 2018 Jun 4;40(2):151–161. doi: 10.1590/2175-8239-JBN-3865

Table 3. Initial immunosuppression.

Regimen, n (%) death (n = 162) control (n = 162)
Induction    
none 52 (32) 65 (40)
basiliximab 96 (59) 80 (49)
anti-thymocyte globulin 14 (9) 17 (11)
Maintenance    
Tacrolimus/mycophenolate 78 (48) 68 (42)
Tacrolimus/azathioprine 54 (33) 56 (35)
Tacrolimus/ mTOR inhibitor 2 (1) 3 (2)
Cyclosporine/mycophenolate 7 (4) 6 (4)
Cyclosporine/azathioprine 3 (2) 13 (8)
Cyclosporine/mTOR inhibitor 5 (3) 4 (3)
Other 13 (8) 12 (8)

mTOR: mammalian target of rapamycin.